Effects of Tibolone and Continuous Combined Conjugated Equine Estrogen/Medroxyprogesterone Acetate on the Endometrium and Vaginal Bleeding: Results of the OPAL Study

This publication has 24 references indexed in Scilit:

• Tissue-selectivity: the mechanism of action of tibolone
  Maturitas, 2004
• Receptor profiling and endocrine interactions of tibolone
  Steroids, 2002
• Bleeding patterns of the hormone replacement therapies in the postmenopausal estrogen and progestin interventions trial*1
  Obstetrics & Gynecology, 2002
• Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
  JAMA, 2002
• Tibolone for Postmenopausal Women: Systematic Review of Randomized Trials
  Journal of Clinical Endocrinology & Metabolism, 2002
• Tibolone: a compound with tissue specific inhibitory effects on sulfatase
  Molecular and Cellular Endocrinology, 2001
• Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate
  Fertility and Sterility, 2001
• Effects of tibolone on the endometrium
  Climacteric, 2001
• Effects of Hormone Replacement Therapy on Endometrial Histology in Postmenopausal Women
  JAMA, 1996
• In vitro evaluation of estrogenic, estrogen antagonistic and progestagenic effects of a steroidal drug (Org OD-14) and its metabolites on human endometrium
  The Journal of Steroid Biochemistry and Molecular Biology, 1990